p|datav0.1news250
opentrade on Manifold ↗
marketsingle market

Will AOH1996 succeed in Phase I trial?

Manifold·Science and Technology
United States
72%
vol cum
M11.2k
vol 24h
M0
spread
n/a
ends
Dec 31, 2027
YES 72¢
NO 28¢

This market concerns AOH1996, a cancer therapeutic reported in this paper. It is currently in Phase I trial. This market resolves to YES, if a Phase II trial is submitted and starts for any type of cancer.

timeline
opened · Aug 3, 2023opencloses · Dec 31, 2027
Will AOH1996 succeed in Phase I trial? · prices over time
−24h
now
no price history yet
volume · 24h windows
no volume history

similar markets

suggested by pdata
Manifoldmanifold
Will AOH1996 be FDA approved before 2040?
yes40¢
M0 24h · 1 market
Kalshikalshi
Will the FDA approve VERVE-102?
Before 203587¢Before 203481¢· 0.0ppBefore 203276¢
+3 others
$0 24h · 6 markets
Polymarketpolymarket
FDA approves Retatrutide this year?
yes3¢▼ 0.6pp
$103 24h · 1 market
Manifoldmanifold
Is the "100% effective against solid tumors" cancer pill AOH1996 paper legit? [see description]
yes24¢
M0 24h · 1 market
Kalshikalshi
Will the FDA approve retatrutide?
Before Jul 1, 202747¢▲ 3.0ppBefore Jan 1, 202714¢▲ 1.0ppBefore Jan 1, 202999¢
+2 others
$10 24h · 5 markets
Manifoldmanifold
Will the VLA15 Lyme Disease vaccine "pass" its phase 3 human trial?
yes76¢
M0 24h · 1 market